Xencor Inc reports results for the quarter ended in January 1 - Earnings Summary

Xencor

07/11/2024 04:19

* Xencor Inc  XNCR.OQ  reported a quarterly adjusted loss
of 71
cents​​ per share for the quarter ended January 1, lower than
the same quarter last year, when the company reported EPS of -40
cents.  The mean expectation of ten analysts for the quarter was
for a loss of 98 cents per share. Wall Street expected
results to range from $-1.20 to -80 cents per share.
    * Revenue fell 81.9% to $10.71 million from a year ago;
analysts
expected $13.29 million. 
    * Xencor Inc's reported EPS for the quarter was a loss of 71
cents​.
    * The company reported a quarterly loss of $45.14 million.
    * Xencor Inc shares had risen by 7.0% this quarter and
gained 1.4%
so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 0.7%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Xencor Inc is
$34.00 
This summary was machine generated from LSEG data November 7 at
04:19 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.98          -0.71          Beat
 Jun. 30 2024      -0.88          -1.07          Missed
 Mar. 31 2024      -0.79          -1.11          Missed
 Dec. 31 2023      -0.09          -0.31          Missed